Rituximab prevented corticosteroid-requiring chronic GVHD Healio Rituximab prophylaxis considerably reduced corticosteroid-requiring chronic graft-vs.-host disease in patients who underwent allogeneic peripheral blood stem cell transplantation, according to results of a prospective, open-label, phase 2 study. The ... |